The DOI matches its Crossref record.
Diagnostic Performance and Description of Morphological Features of Focal Nodular Hyperplasia in Gd-EOB-DTPA-Enhanced Liver Magnetic Resonance Imaging: Results of a Multicenter Trial
Abstract
OBJECTIVES: The aim of this prospective study was to evaluate the diagnostic performance of magnetic resonance imaging (MRI) of the liver with the hepatocellular-specific contrast agent gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) in comparison to precontrast MRI and spiral computed tomography (CT) in the specific diagnosis of focal nodular hyperplasia (FNH) and to describe morphologic features and enhancement pattern of FNH. MATERIALS AND METHODS: In 176 patients from a phase III multicenter trial, 59 confirmed FNHs were present (13 = histopathology; 46 = imaging follow-up within 12 months before or 3 months after the MRI study). MR examination consisted of precontrast T1- and T2-w sequences, T1-weighted (w) dynamic sequences after bolus-injection of 0.025 mmol Gd-EOB-DTPA (Primovist; Bayer Schering Pharma)/kg bodyweight and T1-w sequences with fat saturation in the hepatocyte-phase after 20 minutes. The number of correctly characterized FNHs was evaluated and compared with that determined on spiral CT in an on-site reading (clinical study) and an off-site reading (3 blinded readers). The morphologic appearance and enhancement patterns of the FNHs were evaluated. RESULTS: Characterization with combined pre- and post-MRI (88.1%) was superior to that achieved with biphasic-enhanced spiral CT (84.7%, not significant) and precontrast MRI (67.8%, P < 0.05) in the clinical study and significantly superior to both precontrast MRI and spiral CT for 2 of 3 blinded readers. Complete or partial enhancement of the lesions was present in the early dynamic phase (arterial and portovenous dynamic phase) in 94% and 85%, respectively. The pattern of lesion enhancement in the early dynamic phase was mainly homogenous (78%-80%); the median contrast-to-noise ratio was -5.9 in T1-w precontrast images, 14.0 in the arterial phase, 2.4 in the portovenous phase, and 2.9 in the equilibrium phase. Enhancement in the hepatocyte-phase after 10 and 20 minutes was observed in 88% and 90% of lesions, respectively. CONCLUSIONS: Characterization of FNH provided by Gd-EOB-DTPA-enhanced MRI is superior to that provided by precontrast MRI alone or spiral CT. FNHs show very similar enhancement characteristics to those of other extracellular contrast agents in the early dynamic phase after bolus injection of Gd-EOB-DTPA, after 20 minutes in the liver-specific phase enhancement is regularly seen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Primovist, Eovist: What to expect?
Van Beers, B. E., Pastor, C. M., & Hussain, H. K. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.031 · Cited by 407
Ringe, K. I., Husarik, D. B., Sirlin, C. B., & Merkle, E. M. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.10.4392 · Cited by 388
Tsuboyama, T., Onishi, H., Kim, T., Akita, H., Hori, M., Tatsumi, M., Nakamoto, A., Nagano, H., Matsuura, N., Wakasa, K., et al. (2010) · Radiology · doi:10.1148/radiol.10091557 · Cited by 266
Liver-specific agents for contrast-enhanced MRI: role in oncological imaging
Thian, Y. L., Riddell, A. M., & Koh, D.-M. (2013) · Cancer Imaging · doi:10.1102/1470-7330.2013.0050 · Cited by 64
Gadoxetate acid-enhanced MR imaging for HCC: A review for clinicians
Chanyaputhipong, J., Low, S.-C. A., & Chow, P. K. H. (2011) · International Journal of Hepatology · doi:10.4061/2011/489342 · Cited by 41
Metadata
- Authors
- Zech, C. J., Grazioli, L., Breuer, J., Reiser, M. F., & Schoenberg, S. O.
- Venue
- Investigative Radiology
- Published
- 2008-07
- Volume
- 43
- Issue
- 7
- Pages
- 504-511
- ISSN
- 0020-9996 (ISSN-L)
- OpenAlex
- W1969927333
- Cited by
- 227
- References
- 0
- FWCI
- 17.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diagnostic Performance and Description of Morphological Features of Focal Nodular Hyperplasia in Gd-EOB-DTPA-Enhanced Liver Magnetic Resonance Imaging: Results of a Multicenter Trial. https://app.cochat.ai/papers/10.1097/rli.0b013e3181705cd1
- The paper
- Zech, C. J., Grazioli, L., Breuer, J., Reiser, M. F., & Schoenberg, S. O. (2008). Diagnostic Performance and Description of Morphological Features of Focal Nodular Hyperplasia in Gd-EOB-DTPA-Enhanced Liver Magnetic Resonance Imaging: Results of a Multicenter Trial. Investigative Radiology. https://doi.org/10.1097/rli.0b013e3181705cd1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.